Clicky

SONNET BioTherapeutics, Inc.(SONN)

Description: SONNET BioTherapeutics, Inc. is a biotechnology company that engages in development of bi and tri functional therapies that can simulate or block immune-modulating targets to control cancer. The company uses albumin binding single chain antibody fragment (scFv) for delivery of recombinant human-cytokines (rH-cytokines) and other validated targets. SONNET BioTherapeutics, Inc. was incorporated in 2015 and is based in Princeton, New Jersey.


Keywords: Biotechnology Cancer Biology Immunology Antibody Biochemistry Cytokine Blood Plasma

Home Page: www.sonnetbio.com

SONN Technical Analysis

100 Overlook Center
Princeton, NJ 08540
United States
Phone: 609-375-2227


Officers

Name Title
Dr. Pankaj Mohan Ph.D. Founder, Chairman. CEO & Pres
Dr. John K. Cini Ph.D. Chief Scientific Officer & Co-Founder
Mr. Jay Cross Chief Financial Officer
Ms. Susan Dexter Chief Technical Officer
Dr. Richard T. Kenney FACP, M.D. Chief Medical Officer
Mr. Manuel Dafonseca Head of Clinical Operations

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 9.454
Price-to-Sales TTM: 9.0917
IPO Date: 2006-10-31
Fiscal Year End: December
Full Time Employees: 12
Back to stocks